Cabaletta Bio (CABA) Equity Ratio (2018 - 2025)

Cabaletta Bio's Equity Ratio history runs 8 years deep, the most recent figure standing at 0.68 for Q4 2025.

• In Q4 2025, Equity Ratio fell 17.55% year-over-year to 0.68; the TTM figure through Dec 2025 stood at 0.68 (down 17.55% YoY), while the FY2025 annual figure was 0.68, down 17.55% from the prior year.
• Equity Ratio was 0.68 for Q4 2025 at Cabaletta Bio, down from 0.73 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.96 in Q1 2021 to a low of 0.68 in Q4 2025.
• Historically, Equity Ratio has averaged 0.88 across 5 years, with a median of 0.93 in 2023.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio advanced 4.21% in 2023, then retreated 20.17% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.93 in 2021, then decreased by 4.29% to 0.89 in 2022, then rose by 4.21% to 0.93 in 2023, then retreated by 11.59% to 0.82 in 2024, then decreased by 17.55% to 0.68 in 2025.
• The last three Equity Ratio figures came in at 0.68 (Q4 2025), 0.73 (Q3 2025), and 0.8 (Q2 2025), per Business Quant data.